Incidence and mortality of incidental prostate cancer: a Swedish register-based study

por Andrèn, O, Garmo, H, Mucci, L, Andersson, S-O, Johansson, J-E, Fall, K
Publicado 2009

Body mass index in early and middle-late adulthood and risk of localised, advanced and fatal prostate cancer: a population-based prospective study

por Discacciati, A, Orsini, N, Andersson, S-O, Andrén, O, Johansson, J-E, Wolk, A
Publicado 2011

Dietary cadmium exposure and prostate cancer incidence: a population-based prospective cohort study

por Julin, B, Wolk, A, Johansson, J-E, Andersson, S-O, Andrén, O, Åkesson, A
Publicado 2012

A prospective study of lifetime physical activity and prostate cancer incidence and mortality

por Orsini, N, Bellocco, R, Bottai, M, Pagano, M, Andersson, S-O, Johansson, J-E, Giovannucci, E, Wolk, A
Publicado 2009

MUC-1 gene is associated with prostate cancer death: a 20-year follow-up of a population-based study in Sweden

por Andrén, O, Fall, K, Andersson, S-O, Rubin, M A, Bismar, T A, Karlsson, M, Johansson, J-E, Mucci, L A
Publicado 2007

Benign prostatic hyperplasia and subsequent risk of bladder cancer

por Kang, D, Chokkalingam, A P, Gridley, G, Nyren, O, Johansson, J E, Adami, H O, Silverman, D, Hsing, A W
Publicado 2007

Interleukin-1 receptor antagonist haplotype associated with prostate cancer risk

por Lindmark, F, Zheng, S L, Wiklund, F, Bälter, K A, Sun, J, Chang, B, Hedelin, M, Clark, J, Johansson, J-E, Meyers, D A, Adami, H-O, Isaacs, W, Grönberg, H, Xu, J
Publicado 2005